Variant report
Variant | esv3419013 |
---|---|
Chromosome Location | chr5:27340395-27345693 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:27226976..27228846-chr5:27344849..27346481,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs578110410 | chr5:27340401-27340402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs191958305 | chr5:27340419-27340420 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560836637 | chr5:27340450-27340451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs62347664 | chr5:27340489-27340490 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs549707124 | chr5:27340503-27340504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs560832071 | chr5:27340535-27340536 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs377308343 | chr5:27340569-27340570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs552741199 | chr5:27340621-27340622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549881769 | chr5:27340649-27340650 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372761543 | chr5:27340660-27340661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538818555 | chr5:27340665-27340666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs547324522 | chr5:27340677-27340678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs184335473 | chr5:27340678-27340679 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs189682644 | chr5:27340711-27340712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs554460128 | chr5:27340744-27340745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573675442 | chr5:27340782-27340783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs181237013 | chr5:27340804-27340805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185077960 | chr5:27340872-27340873 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs377235462 | chr5:27340873-27340874 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs368608407 | chr5:27340923-27340924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs59411906 | chr5:27340924-27340925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs111658210 | chr5:27340938-27340939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs199500782 | chr5:27340939-27340940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189094547 | chr5:27340949-27340950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545487208 | chr5:27340984-27340985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs139125632 | chr5:27340999-27341000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115405965 | chr5:27341019-27341020 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs78424904 | chr5:27341020-27341021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs371775161 | chr5:27341023-27341024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs543314508 | chr5:27341072-27341073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs181038697 | chr5:27341083-27341084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs531318839 | chr5:27341084-27341085 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs569347152 | chr5:27341094-27341095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs549843089 | chr5:27341139-27341140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs564989751 | chr5:27341204-27341205 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532066400 | chr5:27341243-27341244 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs547481385 | chr5:27341252-27341253 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs186324100 | chr5:27341253-27341254 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs149388249 | chr5:27341289-27341290 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs548062412 | chr5:27341308-27341309 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538321969 | chr5:27341331-27341332 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569654374 | chr5:27341335-27341336 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs558319760 | chr5:27341346-27341347 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs72729035 | chr5:27341365-27341366 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs143711116 | chr5:27341377-27341378 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs577976951 | chr5:27341384-27341385 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs189553880 | chr5:27341448-27341449 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554262269 | chr5:27341489-27341490 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572656981 | chr5:27341593-27341594 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs370159810 | chr5:27341616-27341617 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Multiple myeloma | 17550852 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 16608533 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Intellectual disability | 22102821 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Compulsive disorder | 18923513 | CNVD |
Epilepsy | 18923513 | CNVD |
Prader-willi syndrome | 18923513 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 18632612 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:27330400-27343800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr5:27341200-27341800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr5:27341400-27341800 | Enhancers | Fetal Kidney | kidney |
4 | chr5:27341600-27342000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr5:27341800-27342800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
6 | chr5:27342400-27343000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr5:27342800-27343000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |